Foresite Capital
VC · San Francisco · United States
Stages
Investment region
Industries
Profile
Foresite Capital is a venture capital firm based in the United States, focusing on investing in healthcare and life sciences companies. Founded by Jim Tananbaum, the firm brings together experts with a mix of healthcare research and financial analysis experience, highlighted by team members such as Richard Lau, who has over 10 years in healthcare research, and Susan Gatrill with extensive experience in venture capital accounting. The firm specializes in the healthcare sector, with investments spanning biotechnology, specialty pharmaceuticals, diagnostics, and medical devices. The check sizes typically range from $10-50 million, and they invest primarily in North America. While the exact AUM is not specified, Foresite Capital has managed several investment funds over its operational history. Notable investments made by Foresite Capital include companies like Intarcia - developing continuous drug delivery technologies, 23andMe - a provider of direct-to-consumer genetic testing, Aledade - supporting primary care doctors, and Innovaccer - a healthcare data activation platform. These investments reflect their strong emphasis on high-growth healthcare companies.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Executive Associate to CEO and Founder, Jim Tananbaum | — | — | — | |
| Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.